Peginteron and c-reactive protein increased Patient Reports February 10, 2012

Peginteron Side Effects Report #5740335-3
Peginteron side effect was reported by a Physician from GERMANY on May 02, 2008. Female patient, weighting 108.0 lb, was diagnosed with malignant melanoma stage iv and was treated with Peginteron. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood calcium decreased, blood sodium decreased, c-reactive protein increased, eosinophil count decreased, laboratory test abnormal. Peginteron dosage: unknown. During the same period patient was treated with SORAFENIB. Patient was hospitalized. Patient recovered.